Zaradenie Idefirixu (imflixidáza) do katalógu pripočítateľných položiek.

Organisation: ExCEEd Orphan s.r.o.

Created at: 10.01.2025

Processed at: 07.04.2026

Question

We beg to request a reconsideration of the application. Resubmission of the application for inclusion of Idefirix (imflixidase) in the catalogue of creditable items. The dossier has been submitted. NIHO evaluation report has been prepared.

We have specified the justification in a previous submission.

Answer

That request has been reassessed in accordance with Chapter 8 of the Methodology for Updating Attributable Items for SK-DRG 2026, available here: https://www.cksdrg.sk/sk/dokumenty/568/Metodika%20aktualizácie%20pripočítateľných%20položiek%20pre%20SK-DRG%202026.pdf

Given that the criteria were met, the Medical Review Panel proceeded to a vote, which is recorded in the minutes available here: https://www.cksdrg.sk/sk/dokumenty/571/Zápisy%20z%20rokovaní%20medicínsko-analytickej%20pracovnej%20skupiny%20s%20hlasovaniami.pdf

The proposed PP has been approved and incorporated into the KPP with reimbursement type B in accordance with the above methodology.